275 related articles for article (PubMed ID: 23835515)
1. New generation of oral mucosal vaccines targeting dendritic cells.
Owen JL; Sahay B; Mohamadzadeh M
Curr Opin Chem Biol; 2013 Dec; 17(6):918-24. PubMed ID: 23835515
[TBL] [Abstract][Full Text] [Related]
2. [PERSPECTIVES OF DEVELOPMENT OF LIVE RECOMBINANT ANTHRAX VACCINES BASED ON OPPORTUNISTIC AND APATHOGENIC MICROORGANISMS].
Popova PY; Mikshis NI
Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):79-89. PubMed ID: 27029122
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
4. Activation of B cells by a dendritic cell-targeted oral vaccine.
Sahay B; Owen JL; Yang T; Zadeh M; Lightfoot YL; Ge JW; Mohamadzadeh M
Curr Pharm Biotechnol; 2013; 14(10):867-77. PubMed ID: 24372255
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-targeted recombinantLactobacilli induce DC activation and elicit specific immune responses against G57 genotype of avian H9N2 influenza virus infection.
Sun Y; Qian J; Xu X; Tang Y; Xu W; Yang W; Jiang Y; Yang G; Ding Z; Cong Y; Wang C
Vet Microbiol; 2018 Sep; 223():9-20. PubMed ID: 30173758
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunization: a review of strategies and challenges.
Patel H; Yewale C; Rathi MN; Misra A
Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
[TBL] [Abstract][Full Text] [Related]
7. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities.
Sloat BR; Cui Z
Pharm Res; 2006 Jun; 23(6):1217-26. PubMed ID: 16718616
[TBL] [Abstract][Full Text] [Related]
8. Mucosal vaccines: Strategies and challenges.
Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
[TBL] [Abstract][Full Text] [Related]
9. Novel vaccine development strategies for inducing mucosal immunity.
Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
[TBL] [Abstract][Full Text] [Related]
10. Mucosal vaccination--an old but still vital strategy.
Długońska H; Grzybowski M
Ann Parasitol; 2012; 58(1):1-8. PubMed ID: 23094329
[TBL] [Abstract][Full Text] [Related]
11. New insights in mucosal vaccine development.
Pavot V; Rochereau N; Genin C; Verrier B; Paul S
Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
[TBL] [Abstract][Full Text] [Related]
12. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
[TBL] [Abstract][Full Text] [Related]
13. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
[TBL] [Abstract][Full Text] [Related]
14. [Mucosal immunity and vaccine development].
Anjuère F; Czerkinsky C
Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226
[TBL] [Abstract][Full Text] [Related]
15. Mucosal vaccine design and delivery.
Woodrow KA; Bennett KM; Lo DD
Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
[TBL] [Abstract][Full Text] [Related]
16. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
Skoble J; Beaber JW; Gao Y; Lovchik JA; Sower LE; Liu W; Luckett W; Peterson JW; Calendar R; Portnoy DA; Lyons CR; Dubensky TW
Infect Immun; 2009 Apr; 77(4):1649-63. PubMed ID: 19168734
[TBL] [Abstract][Full Text] [Related]
17. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
18. Mucosal Lactobacillus vectored vaccines.
Yu Q; Zhu L; Kang H; Yang Q
Hum Vaccin Immunother; 2013 Apr; 9(4):805-7. PubMed ID: 23322214
[TBL] [Abstract][Full Text] [Related]
19. Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine.
Mohamadzadeh M; Durmaz E; Zadeh M; Pakanati KC; Gramarossa M; Cohran V; Klaenhammer TR
Future Microbiol; 2010 Aug; 5(8):1289-96. PubMed ID: 20722604
[TBL] [Abstract][Full Text] [Related]
20. Designing oral vaccines targeting intestinal dendritic cells.
Devriendt B; De Geest BG; Cox E
Expert Opin Drug Deliv; 2011 Apr; 8(4):467-83. PubMed ID: 21375470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
